Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
QuintilesIMS
Citi
Cantor Fitzgerald
Dow
Moodys
Chinese Patent Office
Julphar

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,340,821

« Back to Dashboard

Summary for Patent: 5,340,821
Title: Composition and method for treating Sjoegren syndrome disease
Abstract:A composition for treating a Sjoegren syndrome disease is disclosed. The composition comprising derivative of spirooxathiolane-quinuclidine of the following formula (I), ##STR1## wherein Z is .dbd.CR.sup.1 R.sup.2, wherein R.sup.1 and R.sup.2 may be the same or different and each represents hydrogen, alkyl, cyclopentyl, cyclohexyl, aryl, diarylmethylol, or alkyl which may be substituted by one or more aryl groups, or an acid addition salt thereof, or an acid addition salt thereof, as an effective component. Especially effective is an administration of a hydrochloric acid addition salt of 2-methylspiro(1,3-oxathiolane-5,3')quinuclidine.
Inventor(s): Abe; Nobuaki (Tokyo, JP), Takeshita; Yasuyoshi (Utsunomiya, JP)
Assignee: Snow Brand Milk Products Co., Ltd. (JP)
Application Number:08/088,304
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,340,821
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 5,340,821

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,340,821

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan4-207485Jul 10, 1992

International Family Members for US Patent 5,340,821

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 184483 ➤ Try a Free Trial
Australia 4181993 ➤ Try a Free Trial
Australia 666734 ➤ Try a Free Trial
Canada 2099970 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
QuintilesIMS
Chubb
Baxter
Queensland Health
Argus Health
Boehringer Ingelheim
Colorcon
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.